Arcutis Biotherapeutics, Inc.

ARQTNASDAQHealthcare● Active

$21.23

$-0.72(-3.28%)

Market Cap$2.7B

P/E Ratio—

52W High$31.77

52W Low$12.72

Avg Volume1.5M

Open$21.85

Beta1.52

Overview

Arcutis Biotherapeutics, Inc. (ARQT) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · ARQT · as of Feb 25, 2026

Latest filing snapshot

354

+12+3.51%vs prior year

Arcutis Biotherapeutics, Inc. (ARQT) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

354

Change (1Y)

+12

Growth % (1Y)

+3.51%

Revenue / Employee

$1.06M

Net Income / Employee

$-45.6K

Market Cap

$2.7B

ARQT Employee Count

2019 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-02-25	2025-12-31	354	+12	+3.51%
2025-02-25	2024-12-31	342	+46	+15.54%
2024-02-27	2023-12-31	296	+28	+10.45%
2023-02-28	2022-12-31	268	+121	+82.31%
2022-02-22	2021-12-31	147	+93	+172.22%
2021-02-16	2020-12-31	54	+25	+86.21%
2020-03-19	2019-12-31	29	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

LEGN

Legend Biotech Corporation

2,600$5.7B #2

FOLD

Amicus Therapeutics, Inc.

499$4.5B #3

ARQT

Arcutis Biotherapeutics, Inc.YOU

354$2.7B #4

CGON

CG Oncology, Inc. Common stock

Centessa Pharmaceuticals plc

77$6.1B

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · ARQT peer comparison

About ARQT employees

ARQT Employees · Headcount

Arcutis Biotherapeutics, Inc. (ARQT) employee data is sourced from the annual SEC 10-K filing. As of 2025, Arcutis Biotherapeutics, Inc. had 354 full-time employees globally. Full-time employees only. Global consolidated headcount.

Arcutis Biotherapeutics, Inc. employs 354 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $1.06M, reflecting the company's operational efficiency.

Arcutis Biotherapeutics, Inc.'s workforce increased by 12 (3.51%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Arcutis Biotherapeutics, Inc.'s revenue per employee of $1.06M positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

ARQT Employees · 5 questions

As of the latest SEC 10-K filing (2025), Arcutis Biotherapeutics, Inc. had 354 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Arcutis Biotherapeutics, Inc. employee counthow many employees does Arcutis Biotherapeutics, Inc. haveARQT total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-25